BHWM
ABCL icon

Beaird Harris Wealth Management’s AbCellera Biologics ABCL Stock Holding History

Beaird Harris Wealth Management’s Portfolio ABCL Stock Details ABCL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-600
Closed -$1.78K – 512
2024
Q2 		$1.78K Hold
600
– – ﹤0.01% 546
2024
Q1 		$2.72K Hold
600
– – ﹤0.01% 440
2023
Q4 		$3.43K Hold
600
– – ﹤0.01% 417
2023
Q3 		$2.76K Hold
600
– – ﹤0.01% 342
2023
Q2 		$3.88K Hold
600
– – ﹤0.01% 338
2023
Q1 		$4.52K Hold
600
– – ﹤0.01% 326
2022
Q4 		$6.08K Hold
600
– – ﹤0.01% 386
2022
Q3 		$6K Buy
+600
New +$6.58K ﹤0.01% 322
2022
Q2 		– Sell
-600
Closed -$6K – 399
2022
Q1 		$6K Buy
600
+300
+100% +$2.84K ﹤0.01% 400
2021
Q4 		$4K Buy
+300
New +$4.55K ﹤0.01% 485

Other funds holding ABCL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return